Transforming Care. Delivering Insights.
Omnia Health Solutions is a real-world evidence and outcomes company focused on advancing understanding of GLP-1 therapies and long-term chronic health. Our flagship initiative, The BEACON Platform, is an IRB-approved, national research and engagement ecosystem that includes an ongoing observational study and a patient community designed to generate deeper insight into real-world outcomes, adherence, and lived experience with GLP-1 medications.​
Learn how we're changing the paradigm.
Now Enrolling: The Study
A decentralized, longitudinal study evaluating the real world effectiveness of GLP-1 therapies.
Learn more about enrolling here.
Omnia's network is driven by both patients and primary care teams.
This model is powering The BEACON Study, our flagship effort to track and understand long-term GLP-1 outcomes.
With an IRB-approved protocol,
we capture longitudinal data on adherence, outcomes, and patient experiences over months and years—not just weeks.
"Obesity care is evolving rapidly, and we need solutions that bridge the gap between clinical research and everyday practice. Omnia is uniquely positioned to close that gap, ensuring that innovation reaches the patients who need it most."
– Dr. Holly Lofton, Director of the Medical Weight Management Program at NYU Langone Health
Omnia doesn’t just track outcomes. We improve them.
By connecting patients to evidence-based digital tools like the Mayo Clinic Diet, regular check-ins, and treatment-specific support, we actively enhance adherence and engagement.
